EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Targeting prostaglandin D2 (PGD2) metabolism confers protection against radiotherapy-induced esophageal toxicity

Hangfeng Liu, Hongyu Lin, Sheng Jiang, Jinkang Zhang, Ping Wang, Bo Zhou, Qing Li, Bin Song, Zhenguo Yang, Shuyu Zhang, Xue Ying, Tang Feng und 1 weitere

Journal of Pharmaceutical Analysis · 2026-11 · 101843

DOI: 10.1016/j.jpha.2026.101843 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2026-11. Verfasst von Hangfeng Liu und 12 weiteren Autor:innen. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, H., Lin, H., Jiang, S., Zhang, J., Wang, P., Zhou, B., Li, Q., Song, B., Yang, Z., Zhang, S., Ying, X., Feng, T., & Tu, W. (2026). Targeting prostaglandin D2 (PGD2) metabolism confers protection against radiotherapy-induced esophageal toxicity. Journal of Pharmaceutical Analysis, 101843. https://doi.org/10.1016/j.jpha.2026.101843

Vancouver

Liu H, Lin H, Jiang S, Zhang J, Wang P, Zhou B, et al. Targeting prostaglandin D2 (PGD2) metabolism confers protection against radiotherapy-induced esophageal toxicity. Journal of Pharmaceutical Analysis. 2026:101843. doi:10.1016/j.jpha.2026.101843

BibTeX
@article{Liu2026,
  author = {Liu, Hangfeng and Lin, Hongyu and Jiang, Sheng and Zhang, Jinkang and Wang, Ping and Zhou, Bo and Li, Qing and Song, Bin and Yang, Zhenguo and Zhang, Shuyu and Ying, Xue and Feng, Tang and Tu, Wenling},
  title = {Targeting prostaglandin D2 (PGD2) metabolism confers protection against radiotherapy-induced esophageal toxicity},
  journal = {Journal of Pharmaceutical Analysis},
  year = {2026},
  pages = {101843},
  doi = {10.1016/j.jpha.2026.101843}
}
Kostenlos starten →